Soluble expression of human glycoprotein Ibα in Escherichia coli through replacement of the N-terminal capping domain.

Protein Expr Purif

Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 373-1, Guseong-Dong, Yuseong-gu, Daejeon 305-701, Republic of Korea. Electronic address:

Published: September 2014

Glycoprotein Ibα (GpIbα), a family of LRR (leucine-rich repeat) proteins, is a membrane protein on the platelet, and plays an important role in atherothrombotic events. The complex formation of GpIbα with the von Willebrand Factor (vWF) has been revealed to lead to acute coronary syndrome (ACS) or stroke. A considerable attention has been paid to understand the biological functions of GpIbα and its regulation. However, difficulty with the soluble expression of human GpIbα in bacteria has hampered the relevant research. Herein, we present a soluble expression of GpIbα in Escherichiacoli by replacing the N-terminal capping domain of GpIbα with that of Internalin B using a computational approach. The resulting protein was expressed as a soluble form in E. coli, maintaining its structural feature and binding property for vWF. The present approach can be broadly used for the soluble expression of human LRR proteins in E. coli.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pep.2014.06.001DOI Listing

Publication Analysis

Top Keywords

soluble expression
16
expression human
12
glycoprotein ibα
8
n-terminal capping
8
capping domain
8
gpibα
6
soluble
5
human glycoprotein
4
ibα escherichia
4
escherichia coli
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!